483 Baxter Pharmaceutical Solutions May 2016

483 Baxter Pharmaceutical Solutions May 2016

Michele Forster FDA$595.00 - Available Now

FDA investigators audited the Baxter Pharmaceutical Solutions - Bloomington, IN, United States facility and issued inspectional observations (via FDA 483) on 12 May 2016.

Product details

  • Category: Biologics
  • Inspection end: 12 May 2016
  • Location: Bloomington, United States
  • FEI: 1000115571
Add To Cart